▎药明康德内容团队编辑根据PDUFA的预期目标日期，预计2025年1月，美国FDA将对3款创新药物的批准做出监管决定，本文将对这些疗法进行相关介绍。▲2025年1月有望在美国获批的新药（药明康德内容团队制图，点击可见大图）活性成分：Tabelecle ...

Results ANA Speckled pattern is associated with mild to moderate disease (P=0.02). Most frequent antibodies are anti-dsDNA (63%), SSA (24%) and Ku (17.5%). Anti-cardiolipin (aCL) antibodies are ...

A systematic literature search for clinical reports and reviews published between 2000 and 2008 was undertaken using Pub Med and the Cochrane databases. Search words were "HELLP syndrome", and ...